24 November 2017
News and Views
Links and Services
The most recent issue of Inflammatory Bowel Diseases examines infliximab dependency in pediatric Crohn's disease.
Infliximab is effective for induction and maintenance of remission in Crohn's disease.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors